1. Esophageal Disorders Flashcards

1
Q

Anatomic relationships of the esophagus

A

The cervical esophaguspasses through thethoracic inlet (formed by T1, the first ribs, and the costal cartilage between the first ribs and the manubrium of the sternum) to become the thoracic esophagus

The thoracic esophagussits posterior to the trachea and anterior to the vertebral column. It passes to the right of the thoracic aorta and thoracic duct before deviating to the left, passing through theesophageal hiatus at the level of T10, and sitting anterior to the aorta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gross anatomy of the esophagus

A

Epiglottis - seals larynx to prevent aspiration of bolus

Upper Esophageal Sphincter - ring of skeletal muscle that regulates food entry from pharynx into esophagus and prevents bolus reflux

Lower Esophageal Sphincter - ring of smooth muscle that regulates food entry from esophagus into stomach and prevents acid reflux

Gastroesophageal Junction - point where distal esophagus joins the cardia of the stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Microscopic anatomy of the esophagus

A

(From inside the esophagus –> out)

1. MUCOSA

  • Stratified Squamous Epithelium
  • Lamina Propria - connective tissue containing lymph nodules
  • Muscularis Mucosae - smooth muscle responsible for folds in wall

2. SUBMUCOSA

  • Submucosal Glands - secretes bicarbonate to alkalinize esophageal contents
  • Blood Vessels
  • Submucosal Nerve Plexus - provides autonomic nerve supply to the muscularis mucosae

3. MUSCULARIS

  • Inner Circular Layer of smooth muscle
  • Myenteric Nerve Plexus - controls GI tract motility
  • Outer Longitudinal Layer of smooth muscle

4. ADVENTITIA - connective tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Function of the esophagus

A

Propulsion of food from the pharynx to the stomach via peristalsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanics required for food to enter the stomach

A

For food to enter the stomach, it must to overcome intrathoracic and intraabdominal pressures in equilibrium with each other

Normal intrathoracic pressure is - 5 mm Hg

Normal intraabdominal pressure is + 5 mm Hg

The lower esophageal sphincter exerts pressure of 25 mm Hg to move food into stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factors that contribute to reflux

A

Factors that decrease lower esophageal sphincter pressure

  • Medications that cause LES smooth muscle relaxation (CCB, progesterone, beta agonists)
  • Expiration - diaphragmatic relaxation decreases LES pressure

Factors that increase intraabdominal pressure

  • Pregnancy
  • Obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BARIUM SWALLLOW:

Procedure

Indications

Advantages

A

PROCEDURE:

Patient swallows barium tablets or liquid gastrografin which are followed with fluroscopy:

  • Upper GI Series (UGI) - evaluates esophagus, stomach, duodenum
  • Upper GI Series with Small Bowel Follow Through - evaluates esophagus, stomach, duodenum, jejunum, and ileum
  • Modified Swallow - is conducted by speech pathology and evaluates pharynx/upper esophagus. Important if concerned for aspiration pneumonia

INDICATIONS:

First choice if suspecting:

  • Motility Disorder
  • Mechanical Obstruction
  • GERD

UGI + SBFT is the test of choice for Crohn’s Disease

Modified Swallow is done on patients at risk for Aspiration Pneumonia

ADVANTAGES:

Noninvasive, good screening test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ESOPHAGOGASTRODUODENOSCOPY (EGD) aka UPPER ENDOSCOPY:

Indications

Advantages

A

INDICATIONS:

  • Best to visually identify anatomy
  • Best when tissue is needed for diagnosis
  • Perform an endoscopic ultrasound if you suspect cancer or a mass

ADVANTAGES:

  • Dilate strictures
  • Treat bleeding
  • Place stents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MANOMETRY:

Procedure

Indications

Advantages

A

PROCEDURE:

When you “give the man” local anesthetic, place a catheter intranasally, and measure pressures at various points.

INDICATIONS:

  • Look at how well sphincter squeezes and relaxes
  • Do this before any surgery on the esophagus

ADVANTAGES:

  • No sedation
  • 20-30 minute test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IMPEDANCE and pH MONITORING:

Procedure

Indications

A

PROCEDURE:

  • NG catheter test detects changes in resistance to electrical current across electrodes.
  • pH electrode can detect pH of reflux and the frequency and duration of each episode.

INDICATIONS:

Most sensitive test to detect presence of acid in GERD (take patients off PPIs for 5 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GASTROESOPHAGEAL REFLUX DISEASE (GERD):

Definition

Epidemiology

Risk Factors

A

DEFINITION:

Gastric juice refluxes into the esophagus and oropharynx causing symptoms, tissue injury, or both

EPIDEMIOLOGY:

15 million people have heartburn daily

GERD is the #1 non-cardiac cause of chest pain

RISK FACTORS:

FACTORS THAT DECREASE LES PRESSURE BY RELAXING SMOOTH MUSCLE

  • Smoking / Alcohol
  • Medications (Beta Agonists, CCB, Progesterone)
  • Foods (Caffeine, High Fat, Peppermint)
  • Pregnancy

INCREASED INTRAABDOMINAL PRESSURE

  • Hiatal Hernia
  • Obesity
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GERD:

Etiology

Clinical Presentation

Physical Exam Findings

A

ETIOLOGY:

  1. Dysfunctional LES (due to risk factors)
  2. Transient LES relaxation

Other components:

  • Caustic gastric juice (acid, pepsin, bile, pancreatic enzymes)
  • Sufficient duration of contact
  • Possible immune reaction can cause mucosal changes
  • Atypia of pain receptors in the esophagus plays a role in Reflux Hypersensitivity and Functional Heartburn

CLINICAL PRESENTATION:

TYPICAL:

  • Heartburn
  • Chest pain

ATYPICAL:

  • Asthma/Aspiration
  • Chronic Cough
  • Chronic Throat Clearing
  • Dysphonia
  • Dysphagia
  • Dental Disease
  • Sleep Disturbances / Daytime Somnolence

PHYSICAL EXAM:

Generally normal, but may see:

  • Overweight / obese / gravid abdomen
  • Mild pain with deep palpation of epigastric area
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GERD:

Spectrum

A

Physiologic –> Symptomatic –> Erosive Esophagitis –> Complicated Esophagitis

  • Ulceration
  • Hemorrhage
  • Stricture
  • Barrett’s Adenocarcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GERD:

Initial Diagnostics

Indications for Further Diagnostic Testing

Further Diagnostic Tests

A

INITIAL DIAGNOSTICS:

Diagnosis is based on symptoms and complete response to medications

INDICATIONS FOR FURTHER DIAGNOSTIC TESTING:

  • Concerning symptoms: Atypical Symptoms, Advanced Age, Weight Loss, GI Bleed, Anemia
  • Proton Pump Inhibitor Failure
  • Surgical Planning

FURTHER DIAGNOSTIC TESTS:

Endoscopy - used first if patient has persistent symptoms or complications of GERD

Manometry - used if endoscopy is normal

24 hour ambulatory pH monitoring - gold standard for persistent symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GERD:

Lifestyle Modifications

A
  • Quit smoking, alcohol, meds and foods that relax the LES sphincter
  • Weight loss for overweight patients
  • Elevate head of bed
  • Avoid bedtime snacks
  • Avoid recumbency after meals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GERD:

Medical Management

Medical Management for Refractory Symptoms

A

MEDICAL MANAGEMENT:

Antacids - neutralize acid

  • Occasional / Rescue Use

H2-Receptor Blockers (Ranitidine (ZANTAC), Famotidine (PEPCID) - heal GERD symptoms and signs in 50-65% of patients in a few weeks

  • First line for Mild/Intermittent GERD

Proton Pump Inhibitors (Omeprazole (PRILOSEC), Lansoprazole (PREVACID), Pantoprazole (PROTONIX), Esomeprazole (NEXIUM) - irreversibly bind to H/K ATPase in parietal cells to block acid production. Effective in 80% of patients

  • Mainstay of GERD therapy
  • Don’t take perpetually as there’s a risk of mortality
  • Interacts with Protease Inhibitors and Plavix
  • Adverse Events
    • Hypochlorhydria
      • Bacterial overgrowth –> gastritis, increased risk for gastric cancer
      • Decreased B12 absorption
      • Hypergastrinemia can cause rebound hyperacidity
  • Monitor Magnesium

MEDICAL MANAGEMENT FOR REFRACTORY SYMPTOMS:

  • Alginates - buffer acid
  • Bile Acid Sequestrants (Sulcrafate and Cholestyramine)
  • Baclofen - antispasmodic
  • Metoproclomide (REGLAN) - promotility agent
  • SSRIs, SNRIs, Trazadone, TCAs - reflux hypersensitivity and heartburn
  • Gum - salivation buffers acid and improves motility
17
Q

GERD:

Candidates for Surgery

Surgical Management

A

CANDIDATES FOR SURGERY:

  • Typical symptoms and failed medical therapy
  • Severe esophagitis on upper endoscopy
  • Strictures
  • Barrett’s epithelium without dysplasia or carcinoma

SURGICAL MANAGEMENT:

  • Nissen Fundoplication
  • LINX - magnets used to close LES immediately after swallowing
  • Stretta - radiofrequency applied to tighten LES
18
Q

GERD:

Complications

A
  • Ulceration
  • Hemorrhage
  • Stricture
  • Barrett’s Adenocarcinoma
19
Q

HIATAL HERNIA:

Definition

Types

Clinical Presentation

Management

A

DEFINITION:

Stomach herniates into chest at the hiatus

TYPES:

Sliding - GEJ moves above the diaphragm

Para-esophageal - GEJ at/below diaphragm, fundus above diaphragm

CLINICAL PRESENTATION:

TYPICAL GERD SYMPTOMS

  • Heartburn
  • Chest Pain

ATYPICAL

  • Chest Pain
  • Dyspnea

MANAGEMENT:

  • Same as GERD
  • Nissen Fundoplication
20
Q

ESOPHAGEAL STRICTURE:

Etiology

Clinical Presentation

Management

A

ETIOLOGY:

  • GERD
  • Trauma
  • Malignancy
  • Radiation

CLINICAL PRESENTATION:

  • +/- history of GERD
  • Dysphagia
  • +/- Weight Loss

MANAGEMENT:

  • Dilatation with Biopsy

If symptoms persist, consider steroid injections or stenting

  • Chronic PPI use if GERD related
  • Treat malignancy
21
Q

BARRETT’S ESOPHAGUS:

Epidemiology

Pathophysiology

Clinical Presentation

Diagnosis

Management

A

EPIDEMIOLOGY:

  • M:F ~2:1
  • 1-2% of those undergoing routine EGD
  • 10% if erosive esophagitis present
  • 30% if strictures present
  • Familial clusters present

PATHOPHYSIOLOGY:

  • Reflux injures squamous epithelium
  • Squamous replaced by columnar epithelium during healing as its more protective against gastric acid

CLINICAL PRESENTATION:

  • Can’t differentiate from GERD by symptoms

DIAGNOSIS:

  • Usually an incidental finding on EGD
    • If (+), confirm by a 2nd pathologist
    • No dysplasia - repeat 3-5 years
    • Low-grade dysplasia - repeat 6-12 months, treatment an option
    • High-grade dysplasia - treat or repeat in 3 months

MANAGEMENT:

  • PPIs recommended if patient has esophagitis
  • Anti-reflux Surgery (regression possible and may not prevent cancer)
  • Endoscopic (RFA, PDA) vs Esophagectomy for high grade disease (regression possible and may obscure new metaplasia)
22
Q

BARRETT’S ESOPHAGUS:

Indications for Screening

A

ALL societies recommend against screening in general GERD population

CANDIDATES FOR SCREENING:

  • White
  • Male
  • Age 50+
  • Elevated BMI
  • Chronic GERD
  • Hiatal Hernia
23
Q

ESOPHAGEAL ADENOCARCINOMA:

Definition

Etiology

Clinical Presentation

Diagnostic Evaluation / Staging

Management

Prognosis

A

DEFINITION:

Cancer at the GEJ

ETIOLOGY:

Related to Chronic GERD and Barrett’s esophagus

CLINICAL PRESENTATION:

  • Dysphagia (Eating Less, Taking Smaller Bites)
  • Weight Loss

DIAGNOSIS:

  • Barium Swallow
  • Endoscopy
    • Biopsy
    • Esophageal Ultrasound
  • CT Chest/Abdomen/Pelvis
  • PET - tumor activity, mets

MANAGEMENT:

SYMPTOM CONTROL:

  • Esophageal dilatation and stenting for dysphagia
  • Jejunal/Gastrostomy tube for nutrition

CURATIVE:

  • Endoscopic surgery for superficial cancer
  • Esophagectomy +/ chemo & radiation (5-FU, Cisplatin, Epirubicin are common 1st line regimen)

PALLATIVE:

  • Surgery
  • Brachytherapy
  • RT

PROGNOSIS:

  • Localized (Stage I and some Stage II): 43% have a 5 year survival if treated
  • Metastatic (Stage IV) - SC nodes, lungs, liver, peritoneum, bones: 5% have a 5 year survival rate
24
Q

ESOPHAGEAL SQUAMOUS CELL CARCINOMA:

Definition

Etiology

Clinical Presentation

Diagnostic Evaluation / Staging

Management

Prognosis

A

DEFINITION:

Esophageal cancer that occurs higher in the esophagus than adenocarcinoma

ETIOLOGY:

  • Smoking, Opiate Smoking
  • Alcohol
  • Nitrites, Lye, Hot Tea
  • Dietary Deficiency

CLINICAL PRESENTATION:

  • Dysphagia (Eating Less, Taking Smaller Bites)
  • Weight Loss
  • Dysphonia

DIAGNOSIS:

  • Barium Swallow
  • Endoscopy
    • Biopsy
    • Esophageal Ultrasound
  • CT Chest/Abdomen/Pelvis
  • PET - tumor activity, mets

MANAGEMENT:

SYMPTOM CONTROL:

  • Esophageal dilatation and stenting for dysphagia
  • Jejunal/Gastrostomy tube for nutrition

CURATIVE:

  • Endoscopic surgery for superficial cancer
  • Esophagectomy +/ chemo & radiation (5-FU, Cisplatin, Epirubicin are common 1st line regimen)

PALLATIVE:

  • Surgery
  • Brachytherapy
  • RT

PROGNOSIS:

  • Localized (Stage I and some Stage II): 43% have a 5 year survival if treated
  • Metastatic (Stage IV) - SC nodes, lungs, liver, peritoneum, bones: 5% have a 5 year survival rate
25
Q

Motility Disorders and their Common Clinical Presentation

A

MOTILITY DISORDERS:

  • Achalasia
  • Diffuse Esophageal Spasm
  • Scleroderma

COMMON CLINICAL PRESENTATION:

  • Dysphagia to both solids and liquids
26
Q

ACHALASIA:

Etiology

Pathophysiology

Clinical Presentation

Diagnostic Evaluation

Management

A

ETIOLOGY:

PRIMARY - idiopathic

SECONDARY -

  • Gastric cancer
  • Chagas Disease
  • Viral Infections
  • Neurodegenerative Disorder

PATHOPHYSIOLOGY:

  • Lack of intramural neurons
  • Lack of normal peristalsis
  • Failure of LES relax (opposite of GERD)

CLINICAL PRESENTATION:

  • Modest Weight Loss early on
  • Chest Pain (globus sensation)
  • Dysphagia to both solids and liquids that is aggravated by hurried eating and is better with valsalva

DIAGNOSTIC EVALUATION:

  • Bird’s Beak esophagus found on Barium Swallow
  • LES or GEJ closed on EGD

MANAGEMENT:

Think: BEC MEN

  • Balloon Dilatation
  • Endoscopic Botox
  • CCB
  • Myotomy +/- Fundoplication
  • Esophagectomy (severe cases)
  • Nitroglycerin sublingual
27
Q

DIFFUSE ESOPHAGEAL SPASM:

Etiology

Pathophysiology

Clinical Presentation

Management

Natural Progression

A

ETIOLOGY:

Patchy neural degeneration

PATHOPHYSIOLOGY:

Loss of inhibitory neurons leads to non-peristaltic contractions

CLINICAL PRESENTATION:

  • Dysphagia to both solids and liquids
  • +/- Chest Pain (mimicking an MI)

MANAGEMENT:

  • CCB
  • Nitrates

NATURAL PROGRESSION:

Achalasia

28
Q
  • *SCLERODERMA:**
  • *Pathophysiology**

Clinical Presentation

Diagnostic Evaluation

Management

A

PATHOPHYSIOLOGY:

Atrophy and fibrosis of esophageal wall

CLINICAL PRESENTATION:

  • Dysphagia to both solids and liquids
  • GERD-type symptoms

DIAGNOSTIC EVALUATION:

Stove-pipe Esophagus on Barium Swallow

MANAGEMENT:

  • Soft foods
  • Aggressive GERD therapy
29
Q

Types of Inflammatory Esophagitis

A

TYPES OF INFLAMMATORY ESOPHAGITIS:

  • Pill-Induced
  • Radiation
  • Infectious
  • Corrosive
  • Eosinophilic
30
Q

PILL-INDUCED ESOPHAGITIS:

Etiology

Management

A

ETIOLOGY:

  • Bisphosphonates (Boniva)
  • Antibiotics
  • NSAIDs

MANAGEMENT:

  • Take pills upright
  • Drink lots of water
31
Q

RADIATION-INDUCED ESOPHAGITIS:

Management

A

MANAGEMENT:

  • Stop radiation
  • Viscous Lidocaine
  • Indomethacin
  • Dilatation +/- Feeding Tube
32
Q

INFECTIOUS ESOPHAGITIS:

Etiology

Clinical Presentation

Diagnostic Evaluation

Management

A

ETIOLOGY in immunocompromised:

  • Most Common: Candida, CMV, HSV
  • Other Viruses: HIV, HPV, EBV
  • Fungi: Histo, Blasto, Mucor
  • Parasites: Crypto, PCP
  • Bacterial esophagitis is rare, but TB and MAC possible

CLINICAL PRESENTATION:

  • Acute onset
  • Odynophagia
  • Dysphagia
  • Chest Pain
  • Systemic Symptoms

DIAGNOSTIC EVALUATION:

  • Barium Swallow
  • EGD with Biopsy

MANAGEMENT:

  • Antimicrobial Therapy
  • +/- Steroids
  • Hydration
33
Q

CORROSIVE ESOPHAGITIS:

Pathophysiology

Management

A

PATHOPHYSIOLOGY:

  • Heals by scarring (stricture)

MANAGEMENT:

  • Dilatations
  • Possible Esophagectomy
34
Q

EOSINOPHILIC ESOPHAGITIS:

Etiology

Clinical Presentation

Diagnostic Evaluation

Management

A

ETIOLOGY:

  • Environmental or Food Allergies
  • Asthma/Atopy

CLINICAL PRESENTATION:

  • Caucasian, male kids/teenagers
  • GERD symptoms
  • Dysphagia

DIAGNOSTIC EVALUATION:

Biopsy shows >15 eosinophils/high power field

MANAGEMENT:

  • PPIs
  • Steroids
  • Dietary Elimination